Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth.
about
Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancerUrothelial signaling.Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer.Biology of urothelial tumorigenesis: insights from genetically engineered mice.Recent advances in treatment of advanced urothelial carcinoma.Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs.Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function.Current animal models of bladder cancer: Awareness of translatability (Review)Neural control of the lower urinary tract: peripheral and spinal mechanismsModelling bladder cancer in mice: opportunities and challenges.Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype CarcinomasApical epidermal growth factor receptor signaling: regulation of stretch-dependent exocytosis in bladder umbrella cellsUrothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies.Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response.Diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancerFGFR3b Extracellular Loop Mutation Lacks Tumorigenicity In Vivo but Collaborates with p53/pRB Deficiency to Induce High-grade Papillary Urothelial Carcinoma.Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and ErkNew therapeutic targets in the management of urothelial carcinoma of the bladderRetargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptorRole of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.Expression of Epidermal Growth Factor Receptor and Transforming Growth Factor Alpha in Cancer Bladder: Schistosomal and Non-Schistosomal.When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.Exploring molecular genetics of bladder cancer: lessons learned from mouse modelsRole of STAT3 pathway in genitourinary tumors.Chronic activation of wild-type epidermal growth factor receptor and loss of Cdkn2a cause mouse glioblastoma formation.The role of WNT signalling in urothelial cell carcinoma.Acquired MET expression confers resistance to EGFR inhibition in a mouse model of glioblastoma multiforme.Intrinsic subtypes and bladder cancer metastasis.
P2860
Q28076041-E58FD1F6-EB7D-4B52-9B69-69785F098120Q30440958-94469339-B7DE-4411-9D3B-13B1CF7BAF84Q33403088-132CA86A-941A-49D3-B874-6F545AB28638Q33554361-928E7F81-F7AF-42DC-BCC1-673F08EE2EC8Q33565845-F4ADC211-9AEC-4165-BAAC-955E12125EB6Q33593041-50618CE9-AD41-46D6-BEA2-CD1F92FBB6D7Q33728157-3B736031-73F0-4110-A5FC-088F309D80BEQ33962620-16CFFD8E-9373-4844-B066-E44B89AED758Q34020395-1E15FFF4-B012-4CDA-9883-867DE07B8F76Q35285703-4DA5D082-0366-4B76-8092-61A94D9B04FDQ35612218-DBB1D930-0423-4CCD-B6D2-6EE7D5FB8BF9Q35723633-975B8518-35B5-4A7A-95AF-C9FF02A8EB37Q36061127-01CD1308-3708-4C45-AFB9-6C1111C77D40Q36131259-67C33EB2-4110-4556-9877-7F7C68D5F5C3Q36511054-35A1F615-0357-41D3-AF8D-25D353079E0CQ36882005-36104DED-5AEF-4AA9-8571-6C7544B29365Q37030873-A272DBC7-5775-49B4-AF45-7D4D3D89D9F4Q37305943-A4C95D61-4D46-4048-81B7-1ACAE52DB26CQ37513318-2F19BBE3-2958-40C6-8DD5-0571D9D4D91BQ37655607-8F96EDD7-0A68-4130-918A-D661EFA921B1Q37743090-6C4F2CBC-A503-45B5-8E74-1539B08F64A0Q37933675-8BAC20CA-5629-4B5B-B79C-6BEB0502E918Q37994164-3931DC8B-A35A-4E0F-BB4A-322AD17D17FAQ38776978-C1651F97-769B-4A49-BB32-3025930309A1Q39539196-45AAC0A1-8264-4299-9122-C74370EDB7E3Q40642338-33F94FAE-F3F2-4696-85B2-9A828E982CCCQ41816118-1A685DE9-A5DA-44DC-AD2F-9980EEF6ADDAQ55078504-62C33879-38A9-4BE8-8201-EB99388335AA
P2860
Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Overexpression of epidermal gr ...... promotes bladder tumor growth.
@en
Overexpression of epidermal gr ...... promotes bladder tumor growth.
@nl
type
label
Overexpression of epidermal gr ...... promotes bladder tumor growth.
@en
Overexpression of epidermal gr ...... promotes bladder tumor growth.
@nl
prefLabel
Overexpression of epidermal gr ...... promotes bladder tumor growth.
@en
Overexpression of epidermal gr ...... promotes bladder tumor growth.
@nl
P2093
P1433
P1476
Overexpression of epidermal gr ...... promotes bladder tumor growth
@en
P2093
Ellen Shapiro
Hongying Huang
Zhong-Ting Zhang
P304
P407
P577
2002-07-01T00:00:00Z